Test Menu

Routine Histopathology

The majority of skin biopsises and excisions are successfully analyzed using routine histopathologic examination (H&E). Special stains and ancillary testing are ordered only by the Dermatopathologists when necessary or when requested by the clinician.

Histochemical Special Stains
•Acid-fast Bacillus, Kinyoun’s
•Alcian blue / PAS
•Alcian Blue
•Amyloid, Congo Red
•CAE (Chloroacetate esterase)
•Colloidal Iron
•Diff-Quick Giemsa
•Elastic
•Fite, Melanin
•Fontana-Masson
•GMS, fungal
•Giemsa
•Glycogen
•Gram
•H&E
•Iron
•Masson Trichrome
•Melanin bleach
•Mucicarmine, Mucin
•Oil Red O
•PAP (Papanicolaou)
•PAS (Periodic Acid Schiff’s)
•PAS w/ diastase
•PAS-fungus
•Reticulin/Nuclear Fast Red
•Steiner
•Toluidine blue
•Warthin-Starry
•Wright-Geimsa

Immunofluorescence
•Albumin
•C3
•Fibrin
•IgA
•IgG
•IgM

Immunohistochemistry (IHC)
•ALK-1
•BCL-2
•BCL-6
•BerEP4
•CD1a
•CD3
•CD4
•CD8
•CD20
•CD30
•CD31
•CD34
•CD45 (LCA)
•CD56
•CD61
•CD68
•CD79a
•CD117 (c-kit)
•CD138
•CD163
•Chromogranin A
•CK (Cytokeratin) AE1/AE3 (pankeratin)
•CK 5/6
•CK 7
•CK 20
•Desmin
•E. cadherin
•EMA
•Factor 13a, Xllla
•Glycophorin A
•HHV-8
•HSV-1
•HSV-2
•Mart-1, (Melan A)
•MiTF

•MLH-1
•MSH-2
•MSH-6
•MPO
•NKlC3
•p53
•p63
•Podoplanin
•S-100
•SMA, smooth muscle actin
•SMMhc
•Treponema Pallidum (Syphillis,
Spirochete)
•Tyrosinase
•Vimentin
•VZV (Varicella Zoster)

*Others available on request.

In Situ Hybridization (ISH)
•Human Papilloma Virus (HPV1, 2), High
Risk/Low Risk

Immunology/Molecular Studies
•BRAF Mutational Analysis
•B Cell gene rearrangement
•T Cell Receptor gene
rearrangement
•Flow Cytometry

**Other testing available on request or as needed

News and Events

Cancer survivors may be at higher risk of developing Melanoma. Read report

FDA approves Erivedge, the first drug to treat advanced basal cell carcinoma. Story

Diagnostic Update

KDL now providing FDA-approved BRAF testing for all mestastic melanomas. More

Contact Us

800.772.0951
865.584.1933
clientservices@kdlpathology.com
facebook icon

Stay Connected

Receive the DermPath Update or hear the latest news from KDL Pathology.